2025年的一份报告为7个国家的心脏病学和肿瘤学高级医生规定了公平薪酬基准,以确保支付合乎道德、符合标准的费用,并鼓励早期专家参与药物开发工作。 A 2025 report sets fair pay benchmarks for top doctors in cardiology and oncology across seven countries to ensure ethical, compliant payments and encourage early expert involvement in drug development.

Research And Markets.com的2025年报告为巴西、阿根廷、瑞士、联合王国、澳大利亚、意大利和日本的心脏病学和肿瘤学主要舆论领袖提供了公平市值补偿基准,提供了四个影响等级的行业标准小时和半天费率。 A 2025 report by ResearchAndMarkets.com provides fair-market value compensation benchmarks for cardiology and oncology key opinion leaders (KOLs) in Brazil, Argentina, Switzerland, the UK, Australia, Italy, and Japan, offering industry-standard hourly and half-day rates across four influence levels. 这些数据来自汇总的匿名行业做法,支持合规和可辩护的付款结构,并强调早期KOL参与的战略利益——在临床发展第二阶段之前,目前只有不到25%的公司参与KOL。 The data, derived from aggregated, anonymized industry practices, supports compliant, defensible payment structures and emphasizes the strategic benefit of early KOL engagement—less than 25% of companies currently involve KOLs before phase 2 of clinical development. 这些报告是涵盖多个治疗地区和国家的更广泛系列报告的一部分,旨在降低监管风险,促进符合道德和市场要求的赔偿做法。 The reports, part of a broader series covering multiple therapeutic areas and countries, aim to reduce regulatory risk and promote ethical, market-aligned compensation practices.